Primer Lokalize Kutanöz Amiloidoz ve Diffüz Sistemik Skleroz Birlikteliği: Olgu Sunumu

Öz

Primer lokalize kutanöz amiloidoz ve diffüz sistemik skleroz birlikteliği nadirdir. 15 yıl önce biyopsi ile primer lokalize kutanöz amiloidoz tanısı alan 61 yaşındaki bir kadın hastaya deri ve lokomotor sistem bulguları, kapilleroskopi bulguları ve otoantikor (anti-Scl-70) pozitifliği ile diffüz sistemik skleroz tanısı konulmuştur. Farklı klinik, etiyopatogenetik ve genetik özellikleri olan bu iki hastalık nadiren bir arada görülmektedir.

Anahtar Kelimeler

• Amiloidozis,CREST,Sistemik Skleroz

Co-existence of Primary Localized Cutaneous Amyloidosis and Diffuse Systemic Sclerosis: Case Report

Öz

Co-existence of primary localized cutaneous amyloidosis and diffuse systemic sclerosis is very rare. In a 61-year-old woman who was diagnosed as primary localized cutaneous amyloidosis with biopsy 15 years ago, additional diagnosis of diffuse systemic sclerosis was made based upon skin, locomotor system and capilloroscopy findings and autoantibody (anti- Scl70) positivity. These two autoimmune diseases, which have different aetiopathogenesis as well as diverse clinical and genetic characteristics, are rarely seen together.

Anahtar Kelimeler

• Amyloidosis,CREST,Systemic Sclerosis

Kaynakça

1. 1. Husby G. Nomenclature and classification of amyloid and amyloidosis. J Intern Med. 1992;232(6):511-2.
2. 2. Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc. 1983; 58(10):665-83.
3. 3. Mehrotra K, Dewan R, Kumar JV, Dewan A. Primary Cutaneous Amyloidosis: A Clinical, Histopathological and Immunofluorescence Study. J Clin Diagn Res. 2017;11(8):WC01-WC05.
4. 4. Krishna A, Nath B, Dhir GG, Kumari R, Budhiraja V, Singh K. Study on epidemiology of cutaneous amyloidosis in northern India and effectiveness of dimethylsulphoxide in cutaneous amyloidosis. Indian Dermatol Online J. 2012;3(3):182-86.
5. 5. Al-Ratrout JT, Satti MB. Primary localized cutaneous amyloidosis: A clinicopathologic study from Saudi Arabia. Int J Dermatol. 1997;36(6):428-34.
6. 6. Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;7;390(10103):1685-99.
7. 7. Breathnach SM. Amyloid and Amyloidosis. J Am Acad. Dermatol. 1988;(18); 1-16.
8. 8. Kikuchi N, Sakai E, Nishibu A, Ohtsuka M, Yamamoto T. Primary Localized Cutaneous Amyloidosis in Patients with Scleroderma Acta Derm Venereol. 2010;90(3):326-7.

9. 9. Ogiyama Y, Hayashi Y, Kou C, Matsumoto Y, Ohashi M. Cutaneous amyloidosis in patients with progressive systemic sclerosis. Cutis. 1996; 57(1): 28–32.
10. 10. Summers EM, Kendrick CG. Primary localized cutaneous nodular amyloidosis and CREST syndrome: a case report and review of the literature. Cutis. 2008;82(1):55-9.
11. 11. Shiman M, Ricotti C, Miteva M, Kerdel F, Romanelli P. Primary localized cutaneous nodular amyloidosis associated with CREST (calcinosis, Raynaud’s phenomenon, esophageal motility disorders, sclerodactyly, and telangiectasia) syndrome. Int J Dermatol. 2010;49(2):229-30.